268 related articles for article (PubMed ID: 28970014)
1. Impact of mast cells in mucosal immunity of intestinal inflammation: Inhibitory effect of IL-37.
Conti P; Caraffa A; Ronconi G; Kritas SK; Mastrangelo F; Tettamanti L; Theoharides TC
Eur J Pharmacol; 2018 Jan; 818():294-299. PubMed ID: 28970014
[TBL] [Abstract][Full Text] [Related]
2. Mast cells emerge as mediators of atherosclerosis: Special emphasis on IL-37 inhibition.
Conti P; Lessiani G; Kritas SK; Ronconi G; Caraffa A; Theoharides TC
Tissue Cell; 2017 Jun; 49(3):393-400. PubMed ID: 28420489
[TBL] [Abstract][Full Text] [Related]
3. Link between mast cells and bacteria: Antimicrobial defense, function and regulation by cytokines.
Conti P; Carinci F; Caraffa A; Ronconi G; Lessiani G; Theoharides TC
Med Hypotheses; 2017 Sep; 106():10-14. PubMed ID: 28818263
[TBL] [Abstract][Full Text] [Related]
4. Mast cells are essential intermediaries in regulating IL-33/ST2 signaling for an immune network favorable to mucosal healing in experimentally inflamed colons.
He Z; Song J; Hua J; Yang M; Ma Y; Yu T; Feng J; Liu B; Wang X; Li Y; Li J
Cell Death Dis; 2018 Dec; 9(12):1173. PubMed ID: 30518915
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 family cytokines and mast cells: activation and inhibition.
Gallenga CE; Pandolfi F; Caraffa Al; Kritas SK; Ronconi G; Toniato E; Martinotti S; Conti P
J Biol Regul Homeost Agents; 2019 Jan-Feb,; 33(1):1-6. PubMed ID: 30656901
[TBL] [Abstract][Full Text] [Related]
6. Stimulated mast cells release inflammatory cytokines: potential suppression and therapeutical aspects.
Varvara G; Tettamanti L; Gallenga CE; Caraffa Al; D'Ovidio C; Mastrangelo F; Ronconi G; Kritas SK; Conti P
J Biol Regul Homeost Agents; 2018; 32(6):1355-1360. PubMed ID: 30574739
[TBL] [Abstract][Full Text] [Related]
7. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Woolley DE; Tetlow LC
Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
[TBL] [Abstract][Full Text] [Related]
8. Mast cell and cancer with special emphasis on il-37 an anti-inflammatory and inhibitor of innate immunity: new frontiers.
Carinci F; Lessiani G; Spinas E; Kritas SK; Ronconi G; Caraffa Al; Conti P
J Biol Regul Homeost Agents; 2016; 30(4):945-950. PubMed ID: 28078840
[TBL] [Abstract][Full Text] [Related]
9. Activated Mast Cells Mediate Low-Grade Inflammation in Type 2 Diabetes: Interleukin-37 Could Be Beneficial.
Conti P; Ronconi G; Kritas SK; Caraffa A; Theoharides TC
Can J Diabetes; 2018 Oct; 42(5):568-573. PubMed ID: 29885882
[TBL] [Abstract][Full Text] [Related]
10. IL-33 mediates allergy through mast cell activation: Potential inhibitory effect of certain cytokines.
Tettamanti L; Kritas SK; Gallenga CE; D'Ovidio C; Mastrangelo F; Ronconi G; Caraffa Al; Toniato E; Conti P
J Biol Regul Homeost Agents; 2018; 32(5):1061-1065. PubMed ID: 30334399
[TBL] [Abstract][Full Text] [Related]
11. Progression in migraine: Role of mast cells and pro-inflammatory and anti-inflammatory cytokines.
Conti P; D'Ovidio C; Conti C; Gallenga CE; Lauritano D; Caraffa A; Kritas SK; Ronconi G
Eur J Pharmacol; 2019 Feb; 844():87-94. PubMed ID: 30529470
[TBL] [Abstract][Full Text] [Related]
12. Impact of mast cells in depression disorder: inhibitory effect of IL-37 (new frontiers).
Conti P; Caraffa A; Ronconi G; Conti CM; Kritas SK; Mastrangelo F; Tettamanti L; Theoharides TC
Immunol Res; 2018 Jun; 66(3):323-331. PubMed ID: 29907890
[TBL] [Abstract][Full Text] [Related]
13. Lipid-rich enteral nutrition regulates mucosal mast cell activation via the vagal anti-inflammatory reflex.
de Haan JJ; Hadfoune M; Lubbers T; Hodin C; Lenaerts K; Ito A; Verbaeys I; Skynner MJ; Cailotto C; van der Vliet J; de Jonge WJ; Greve JW; Buurman WA
Am J Physiol Gastrointest Liver Physiol; 2013 Sep; 305(5):G383-91. PubMed ID: 23812038
[TBL] [Abstract][Full Text] [Related]
14. Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells.
Conti P; Carinci F; Lessiani G; Spinas E; Kritas SK; Ronconi G; Caraffa A; Theoharides TC
Immunol Res; 2017 Oct; 65(5):982-986. PubMed ID: 28748328
[TBL] [Abstract][Full Text] [Related]
15. Mast cells participate in allograft rejection: can IL-37 play an inhibitory role?
Conti P; Caraffa A; Ronconi G; Kritas SK; Mastrangelo F; Tettamanti L; Frydas I; Theoharides TC
Inflamm Res; 2018 Sep; 67(9):747-755. PubMed ID: 29961151
[TBL] [Abstract][Full Text] [Related]
16. Mast cell in innate immunity mediated by proinflammatory and antiinflammatory IL-1 family members.
Robuffo I; Toniato E; Tettamanti L; Mastrangelo F; Ronconi G; Frydas I; Caraffa Al; Kritas SK; Conti P
J Biol Regul Homeost Agents; 2017; 31(4):837-842. PubMed ID: 29254286
[TBL] [Abstract][Full Text] [Related]
17. Impact of TNF and IL-33 Cytokines on Mast Cells in Neuroinflammation.
Conti P; Ronconi G; Lauritano D; Mastrangelo F; Caraffa A; Gallenga CE; Frydas I; Kritas SK; Carinci F; Gaudelli F; Annicchiarico C; D'Ovidio C
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542222
[TBL] [Abstract][Full Text] [Related]
18. Mast Cell Biology at Molecular Level: a Comprehensive Review.
Elieh Ali Komi D; Wöhrl S; Bielory L
Clin Rev Allergy Immunol; 2020 Jun; 58(3):342-365. PubMed ID: 31828527
[TBL] [Abstract][Full Text] [Related]
19. Mast Cells in Cardiac Fibrosis: New Insights Suggest Opportunities for Intervention.
Legere SA; Haidl ID; Légaré JF; Marshall JS
Front Immunol; 2019; 10():580. PubMed ID: 31001246
[TBL] [Abstract][Full Text] [Related]
20. Fc gamma receptor signaling in mast cells links microbial stimulation to mucosal immune inflammation in the intestine.
Chen X; Feng BS; Zheng PY; Liao XQ; Chong J; Tang SG; Yang PC
Am J Pathol; 2008 Dec; 173(6):1647-56. PubMed ID: 18974296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
